This policy watch examines the implications of new proposed regulations that would allow Medicare and require Medicaid to cover drugs used to treat obesity, including a relatively new class of highly effective but costly drugs known as GLP-1s.
This policy watch examines the implications of new proposed regulations that would allow Medicare and require Medicaid to cover drugs used to treat obesity, including a relatively new class of highly effective but costly drugs known as GLP-1s.
The GLP-1 battle heats up with new preliminary data from Eli Lilly...
ByglobalreutersDecember 4, 2024Bowel cancer vs colon cancer are two common types of cancer that...
ByglobalreutersDecember 4, 2024
Leave a comment